World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
64
Citations
14838
World Ranking
1740
National Ranking
874

Ruth Lupu publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Ruth Lupu sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 178 publications — 50th percentile

50% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Ruth Lupu D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Ruth Lupu sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 64 D-Index — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Ruth Lupu is affiliated with the Mayo Clinic in the United States, where they contribute to research primarily in the fields of Biochemistry, Genetics and Molecular Biology, and Medicine. Their scientific work is concentrated on cancer biology, with a strong focus on cancer research and molecular biology. Oncology, pulmonary and respiratory medicine, and pharmacology also form part of their research scope.

The main topics addressed in Ruth Lupu's work include:

  • Cancer, Lipids, and Metabolism
  • Cancer, Hypoxia, and Metabolism
  • Peroxisome Proliferator-Activated Receptors
  • Lung Cancer Treatments and Mutations
  • Cancer Immunotherapy and Biomarkers
  • RNA modifications and cancer
  • HER2/EGFR in Cancer Research

Ruth Lupu has co-authored numerous papers with several frequently collaborating researchers, notably:

  • Javier A. Menéndez (16 publications)
  • Elisabet Cuyàs (15 publications)
  • Sara Verdura (15 publications)
  • Travis Vander Steen (9 publications)
  • Begoña Martı́n-Castillo (6 publications)

Their research is regularly published in journals such as:

  • Cancers (3 publications)
  • Annals of Oncology (3 publications)
  • Cell Death Discovery (2 publications)
  • Expert Opinion on Therapeutic Targets (2 publications)
  • International Journal of Molecular Sciences (2 publications)

Some of Ruth Lupu's recent papers include:

  • Fatty acid synthase (FASN) regulates the mitochondrial priming of cancer cells, 2021, Cell Death and Disease
  • Fatty Acid Synthase Confers Tamoxifen Resistance to ER+/HER2+ Breast Cancer, 2021, Cancers
  • Fatty acid synthase: a druggable driver of breast cancer brain metastasis, 2022, Expert Opinion on Therapeutic Targets
  • Fatty Acid Synthase Is a Key Enabler for Endocrine Resistance in Heregulin-Overexpressing Luminal B-Like Breast Cancer, 2020, International Journal of Molecular Sciences
  • Tumor Cell-Intrinsic Immunometabolism and Precision Nutrition in Cancer Immunotherapy, 2020, Cancers

Best Publications

  • Reciprocal interactions between β1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: A different perspective in epithelial biology

    Fei Wang;Valerie M. Weaver;Ole W. Petersen;Carolyn A. Larabell

  • Direct interaction of a ligand for the erbB2 oncogene product with the EGF receptor and p185erbB2.

    Ruth Lupu;Ramon Colomer;Gerhard Zugmaier;Jay Sarup

  • Oleic acid, the main monounsaturated fatty acid of olive oil, suppresses Her-2/neu (erbB-2) expression and synergistically enhances the growth inhibitory effects of trastuzumab (Herceptin™) in breast cancer cells with Her-2/neu oncogene amplification

    J. A. Menendez;L. Vellon;R. Colomer;R. Lupu;R. Lupu

  • Expression and regulation of estrogen receptor beta in human breast tumors and cell lines.

    Unknown

  • Expression of Estrogen Receptor β Messenger RNA Variant in Breast Cancer

    Unknown

  • Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells.

    A. Vazquez-Martin;R. Colomer;J. Brunet;R. Lupu

  • Pharmacological inhibitors of Fatty Acid Synthase (FASN)--catalyzed endogenous fatty acid biogenesis: a new family of anti-cancer agents?

    Ruth Lupu;Javier A Menendez;Javier A Menendez

  • Antibody‐induced growth inhibition is mediated through immunochemically and functionally distinct epitopes on the extracellular domain of the c‐erbb‐2 (her‐2/neu) gene product p185

    Fengji Xu;Ruth Lupu;Gustavo C. Rodriguez;Regina S. Whitaker

  • Involvement of Heregulin-β2 in the Acquisition of the Hormone-independent Phenotype of Breast Cancer Cells

    Unknown

  • Transforming Growth Factor β1 Induces Cachexia and Systemic Fibrosis without an Antitumor Effect in Nude Mice

    Gerhard Zugmaier;Soonmyoung Paik;George Wilding;Cornelius Knabbe

  • A genomic explanation connecting “Mediterranean diet”, olive oil and cancer: Oleic acid, the main monounsaturated Fatty acid of olive oil, induces formation of inhibitory “PEA3 transcription factor-PEA3 DNA binding site” complexes at the Her-2/neu (erbB-2) oncogene promoter in breast, ovarian and stomach cancer cells

    Javier A. Menendez;Adriana Papadimitropoulou;Adriana Papadimitropoulou;Luciano Vellon;Luciano Vellon;Ruth Lupu;Ruth Lupu

  • Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.

    Javier A. Menendez;Luciano Vellon;Luciano Vellon;Ramon Colomer;Ruth Lupu;Ruth Lupu

  • The angiogenic factor CYR61 in breast cancer: molecular pathology and therapeutic perspectives.

    J A Menéndez;I Mehmi;D W Griggs;R Lupu

  • Characterization of a growth factor that binds exclusively to the erbB-2 receptor and induces cellular responses

    Ruth Lupu;Ramon Colomer;Bhanu Kannan;Marc E. Lippman

  • Neu Differentiation Factor (Heregulin) Induces Expression of Intercellular Adhesion Molecule 1: Implications for Mammary Tumors

    Sarah S. Bacus;Andrei V. Gudkov;Carolyn R. Zelnick;Dot Chin

  • erbB-2 antisense oligonucleotides inhibit the proliferation of breast carcinoma cells with erbB-2 oncogene amplification.

    R. Colomer;R. Lupu;S. S. Bacus;E. P. Gelmann

  • A ligand for the erbB-2 oncogene product (gp30) induces differentiation of human breast cancer cells

    Sarah S. Bacus;Eliezer Huberman;Dot Chin;Kaoru Kiguchi

  • Mediterranean dietary traditions for the molecular treatment of human cancer: anti-oncogenic actions of the main olive oil's monounsaturated fatty acid oleic acid (18:1n-9)

    Javier A Menendez;Ruth Lupu

  • Increased miR-708 Expression in NSCLC and Its Association with Poor Survival in Lung Adenocarcinoma from Never Smokers

    Jin Sung Jang;Hyo Sung Jeon;Zhifu Sun;Marie Christine Aubry

  • Oncogenic properties of the endogenous fatty acid metabolism: molecular pathology of fatty acid synthase in cancer cells.

    Javier A Menendez;Ruth Lupu

Frequent Co-Authors

Javier A. Menendez
Javier A. Menendez Catalan Institute of Oncology
Judith Campisi
Judith Campisi Buck Institute for Research on Aging
Erik W. Thompson
Erik W. Thompson Queensland University of Technology
George Kemble
George Kemble Sagimet Biosciences
María J. Vicent
María J. Vicent Cardiff University
Jorge Joven
Jorge Joven Rovira i Virgili University
Edward B. Leof
Edward B. Leof Mayo Clinic
Marvin C. Gershengorn
Marvin C. Gershengorn National Institutes of Health
Vicente Micol
Vicente Micol Miguel Hernandez University
Walter Berger
Walter Berger Medical University of Vienna

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a career in Molecular Biology, there are several related online degrees and pathways in the healthcare and biosciences fields. Many students explore different routes to advance their qualifications or shift to specialized roles.

For those interested in clinical applications or direct patient care, understanding how long does it take to become a nurse practitioner can help you plan your education timeline. Alternatively, registered nurses aiming to advance can find accelerated options like the rn to bsn online programs, which offer degree completion in as little as six months.

Those with an associate degree in nursing can leverage specialized bridge programs, including adn to np pathways, to fast-track their graduate studies and maximize career flexibility. For non-nurses considering a rapid transition into advanced practice, direct entry msn programs for non-nurses online allow candidates from diverse scientific backgrounds—such as Molecular Biology—to enter the nursing field efficiently.

Exploring these related online degrees can open doors to diverse and rewarding careers in healthcare and research.

Best Scientists Citing Ruth Lupu

Trending Scientists

Recently Published Articles